Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

MYGNMYGN
Showing 8 of 15 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in MYRIAD GENETICS INC

Yes. Qube Research & Technologies holds 1,665,835 shares of MYGN (Myriad Genetics), worth $9.5M, as of its Q2 2026 13F filing. It reduced the position by 24,626 shares (-1.5%) from Q1 2026. Qube Research & Technologies has held MYGN since Q2 2024, across 9 quarterly 13F filings.

Current Value

$9.5M

Current Shares

1.7M

Total Value Change

-$4.4M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.7M
-1.5%
$9.5M0.0%$5.71
0
2026-Q1
Increased
1.7M
+93.6%
$7.6M0.0%$4.50
44
2025-Q4
Decreased
873,126
-26.4%
$5.4M0.0%$6.15
0
2025-Q3
Decreased
1.2M
-42.2%
$8.6M0.0%$7.23
0
2025-Q2
Increased
2.1M
+44.7%
$10.9M0.0%$5.31
38
2025-Q1
Increased
1.4M
+41.6%
$12.6M0.0%$8.87
37
2024-Q4
Increased
1M
+96.9%
$13.7M0.0%$13.71
45
2024-Q3
Increased
508,624
+618.6%
$13.9M0.0%$27.39
45

Other major holders of MYGN: BlackRock, Inc., BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used